Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer

NCT00385996 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-small Cell Lung

Interventions

DRUG: Tarceva (Erlotinib)

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]